MedTrace Logo

A Pilot Dose Ranging Study of Spinosad Creme Rinse

NCT00858481 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-10-20

No results posted yet for this study

Summary

A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.

Conditions

  • Pediculosis Capitis
  • Head Lice

Interventions

DRUG

Spinosad Creme Rinse - Vehicle Control

One or two, 10-minute topical applications (7 days apart)

DRUG

Spinosad Creme Rinse

0.5% Spinosad Creme Rinse: one or two, 10-minute topical applications (7 days apart)

DRUG

Spinosad Creme Rinse

1.0% Spinosad Creme Rinse: one or two, 10-minute topical applications (7 days apart)

DRUG

Spinosad Creme Rinse

2.0% Spinosad Creme Rinse - one or two, 10-minute topical applications (7 days apart)

Sponsors & Collaborators

  • ParaPRO LLC

    lead INDUSTRY

Principal Investigators

  • Dyal Garg, Ph.D. · Hill Top Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-11-30
Completion
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00858481 on ClinicalTrials.gov